# International Flavors & Fragrances Inc. – Consensus ‘hold’ rating and 6.3% Upside Potential

- Link: https://www.directorstalkinterviews.com/international-flavors-fragrances-inc.consensus-hold-rating-and-6.3-upside-potential/4121132374
- Published: 2023-11-09T12:17:14+00:00
- Author: Charlotte Edwards

**International Flavors & Fragrances Inc.** which can be found using ticker (IFF)
now have 19 market analysts covering the stock. The analyst consensus now points
to a rating of ‘hold’. The range between the high target price and low target price
is between $105.00 and $57.00 calculating the average target price we see $76.11.
Now with the previous closing price of $71.59 and the analysts are correct then 
we can expect a percentage increase in value of 6.3%. The 50 day MA is $67.69 and
the 200 moving average now moves to $81.44. The market cap for the company is 18.13B.
The stock price for the company is currently $71.02 USD

 The potential market cap would be $19,272,623,912 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 1183.67, revenue per share of $45.57
and a 1.08% return on assets.

International Flavors & Fragrances Inc. is a creator and manufacturer of food, beverage,
health and biosciences, scent and pharma solutions and complementary adjacent products.
The Company’s segments include Nourish, Health & Biosciences, Scent and Pharma Solutions.
The Nourish segment comprises of ingredients, flavors and food designs, with a diversified
portfolio across natural and plant-based specialty food ingredients, flavor compounds,
and savory solutions and inclusions. The Health & Biosciences comprises of health,
cultures and food enzymes, home and personal care, animal nutrition and grain processing.
The Scent segment comprises of fragrance compounds, including fine fragrances and
consumer fragrances; fragrance ingredients, and cosmetic active ingredients. The
Pharma Solutions segment produces a portfolio that includes cellulosics and seaweed-
based pharmaceutical excipients, used to improve the functionality and delivery 
of active pharmaceutical ingredients.

Share on: